Maternal antibody inhibits both cellular and humoral immunity in response to measles vaccination at birth

Virology

Volumn 350, Issue 2, 2006, Pages 429-432

  Premenko Lanier, Mary ^a   Hodge, Gregory ^a   Rota, Paul ^b   Tamin, Azaibi ^b   Bellini, William ^b   McChesney, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Immunity; Infant; Nonhuman primate; Vaccine measles

Indexed keywords

GAMMA INTERFERON; MATERNAL ANTIBODY; MEASLES VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; INFECTION; MACACA; MALE; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RASH; T LYMPHOCYTE; VIREMIA; WILD TYPE;

ANTIBODY FORMATION; FEMALE; HUMANS; IMMUNITY, CELLULAR; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; MEASLES VACCINE; PREGNANCY; VACCINATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MEASLES VIRUS;

EID: 33745479092     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.02.029     Document Type: Article

References (19)

1. Albrecht P., Ennis F., Saltzman E., and Krugman S. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J. Pediatr. 91 (1977) 715-718
2. Atmar R.L., Englund J.A., and Hammill H. Complications of measles during pregnancy. Clin. Infect. Dis. 14 (1992) 217-226
3. Bertley F.M., Ibrahim S.A., Libman M., and Ward B.J. Measles vaccination in the presence of maternal antibodies primes for a balanced humoral and cellular response to revaccination. Vaccine 23 (2004) 444-449
4. Betta Ragazzi S.L., De Andrade Vaz-de-Lima L.R., Rota P., Bellini W.J., Gilio A.E., Costa Vaz F.A., and Durigon E.L. Congenital and neonatal measles during an epidemic in Sao Paulo, Brazil in 1997. Pediatr. Infect. Dis. J. 24 (2005) 377-378
5. Burstrom B., Aaby P., and Mutie D.M. Measles in infants: a review of studies on incidence, vaccine efficacy and mortality in east Africa. East Afr. Med. J. 72 (1995) 155-161
6. Chappuis G. Neonatal immunity and immunisation in early age: lessons from veterinary medicine. Vaccine 16 (1998) 1468-1472
7. Erdman D., Anderson L., Adams D., Stewart J., Markowitz L., and Bellini W. Evaluation of monoclonal antibody-based capture enzyme immuno-assay for detection of specific antibodies to measles virus. J. Clin. Microbiol. 20 (1991) 2874-2880
8. Gans H., Yasukawa L., Rinki M., DeHovitz R., Forghani B., Beeler J., Audet S., Maldonado Y., and Arvin A.M. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J. Infect. Dis. 184 (2001) 817-826
9. Gans H., DeHovitz R., Forghani B., Beeler J., Maldonado Y., and Arvin A.M. Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine 21 (2003) 3398-3405
10. Hummel K.B., Erdman D.D., Heath J., and Bellini W.J. Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J. Clin. Microbiol. 30 (1992) 2874-2880
11. Kalergis A.M., and Ravetch J.V. Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J. Exp. Med. 195 (2002) 1653-1659
12. McChesney M.B., Miller C.J., Rota P.A., Zhu Y., Antipa L., Lerche N.W., Ahmed R., and Bellini W.J. Experimental measles: I. Pathogenesis in the normal and the immunized host. Virology 233 (1997) 74-84
13. Premenko-Lanier M., Rota P.A., Rhodes G., Verhoeven D., Barouch D.H., Lerche N.W., Letvin N.L., Bellini W.J., and McChesney M.B. DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate. Virology 307 (2003) 67-75
14. Regnault A., Lankar D., Lacabanne V., Rodriguez A., Thery C., Rescigno M., Saito T., Verbeek S., Bonnerot C., Ricciardi-Castagnoli P., and Amigorena S. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189 (1999) 371-380
15. Siegrist C.-A., Cordova M., Brandt C., Barrios C., Berney M., Tougne C., Kovarik J., and Lambert P.-H. Determinants of infant responses to vaccines in presence of maternal antibodies. Vaccine 16 (1998) 1409-1414
16. van Binnendijk R., Poelen C., van Amerongen G., de Vries P., and Osterhaus A. Protective immunity in macaques vaccinated with live attenuated, recombinant and subunit measles vaccines in the presence of passively acquired antibodies. J. Infect. Dis. 175 (1997) 524-532
17. van den Hof S., Wallinga J., Widdowson M.A., and Conyn-van Spaendonck M.A. Protecting the vaccinating population in the face of a measles epidemic: assessing the impact of adjusted vaccination schedules. Epidemiol. Infect. 128 (2002) 47-57
18. Zhu Y., Heath J., Collins J., Greene T., Antipa L., Rota P., Bellini W., and McChesney M. Experimental measles: II. Infection and immunity in the rhesus macaque. Virology 233 (1997) 85-92
19. Zhu Y., Rota P., Wyatt L., Tamin A., Rozenblatt S., Lerche N., Moss B., Bellini W., and McChesney M. Evaluation of recombinant vaccinia virus-measles vaccines in infant rhesus macaques with preexisting measles antibody. Virology 276 (2000) 202-213